2009 H1N1 Influenza Vaccine Consent Form
Information about Child to Receive Vaccine (please print) STUDENT’S NAME (Last) STUDENT’S DATE OF BIRTH month_________ day________ year __________ PARENT/LEGAL GUARDIAN’S NAME (Last) STUDENT’S AGE STUDENT’S GENDER PARENT/GUARDIAN DAYTIME PHONE NUMBER: SCHOOL NAME
Screening for Vaccine Eligibility If your child has already received a dose of the 2009 H1N1 influenza vaccine, please tell us the dates and type of vaccination. Date received: month ____day____year_______
Date received: month ____day____year_______
The following questions will help us to know if your child can get the 2009 H1N1 influenza vaccine. Please mark YES or NO for each question. If you answer “NO” to all four of the following questions, your child can probably get the influenza vaccine. If you answer “YES” to one or more of the following four questions, you must obtain the vaccine from your doctor.
1. Does your child have a serious allergy to eggs?
2. Does your child have any other allergies? Please list: _________________________________________________
3. Has your child ever had a serious reaction to a previous dose of flu vaccine?
4. Has your child ever had Guillain-Barré Syndrome (a type of temporary severe muscle weakness) within 6 weeks after
B. There are two kinds of 2009 H1N1 influenza vaccine, the nasal spray and the shot or injection. Your answers to the following questions will help us know which of the two kinds of vaccine your child can get.
1. Has your child received any vaccines (not just flu) in the past month? If yes, please list the vaccines on the next line.
Vaccine: ___________________________________ Date given: month______day_______year___________
2. Does your child have any of the following chronic health conditions such as: asthma (active wheezing), diabetes, or
disease of the lungs, heart, kidneys, liver, neuro-muscular (such as seizures, cerebral palsy, etc.), or blood (such as sickle cell anemia)
3. Is your child on long-term aspirin or aspirin-containing therapy (for example, does your child take aspirin every day)?
4. Does your child have a weak immune system (for example, from HIV, cancer, or medications such as steroids or those
6. Does your child have close contact with a person who needs care in a protected environment (for example, someone who
has recently had a bone marrow transplant)?
If you have further questions regarding the 2009 H1N1 or season influenza vaccines please call 1-866-278-7134. CONSENT FOR CHILD’S VACCINATION AND RELEASE OF VACCINATION INFORMATION: I have read or had explained to me the information contained in the 2009-2010 Vaccine Information Statement for the 2009 H1N1 influenza vaccines and understand the risks and benefits of the vaccine. I have had a chance to ask questions which have been answered to my satisfaction. I understand the benefits and risks of the H1N1 and seasonal flu vaccines and request that my child receive the correct number of doses of H1N1 flu vaccine and/or the seasonal flu vaccine. I authorize disclosure of this vaccination information to the school named above, public health officials, and other health care professionals. I understand that this vaccination will be recorded in the Oklahoma State Immunization Information System (OSIIS) for the purposes of sharing vaccination information with other health care providers and tracking vaccine inventory only. Signature of Parent/Guardian
Derma Klausur Sommersemester 2002 Frage 1 Bei der chronisch stationären Psoriasis vulgaris ist folgende Lokaltherapie geeignet: 1. Frage 2 Welche sind die häufigsten spezifischen Haut- und Schleimhautveränderungen bei Lues II 1. Frage 3 Zu den nichtinfektiösen granuIomatösen Dermatosen zählen: Frage 4 Welche bullöse Autoimmundermatose ist in der Regel mit einer glutensensitiven Entero
GLOBALIZATION: WHAT IS NEW; EFFECTIVE GLOBAL Marketing Department, Bloomsburg University, Pennsylvania, Distinguished Professor Emeritus of Marketing and International Business, Concordia University, Montreal, and Distinguished Visiting Professor International Business, Helsinki Professor of International Business, Helsinki School of Economics Abstract What is new and important about glob